ZTS vs. ELAN
ZTS (Zoetis Inc.) and ELAN (Elanco Animal Health Incorporated) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 5 years, ZTS returned -15.30%/yr vs -7.91%/yr for ELAN. At a 0.45 correlation, their price movements are largely independent.
Performance
ZTS vs. ELAN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZTS achieves a -38.40% return, which is significantly lower than ELAN's 2.43% return.
ZTS
- 1D
- 1.25%
- 1M
- -5.51%
- YTD
- -38.40%
- 6M
- -37.26%
- 1Y
- -50.40%
- 3Y*
- -22.07%
- 5Y*
- -15.30%
- 10Y*
- 6.02%
ELAN
- 1D
- -3.01%
- 1M
- 6.67%
- YTD
- 2.43%
- 6M
- 4.32%
- 1Y
- 73.63%
- 3Y*
- 33.15%
- 5Y*
- -7.91%
- 10Y*
- —
ZTS vs. ELAN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ZTS Zoetis Inc. | -38.40% | -21.75% | -16.63% | 35.91% | -39.51% | 48.26% | 25.76% | 55.71% | -3.84% |
ELAN Elanco Animal Health Incorporated | 2.43% | 86.87% | -18.72% | 21.93% | -56.94% | -7.47% | 4.14% | -6.60% | -2.23% |
Correlation
The correlation between ZTS and ELAN is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2018 | 0.45 |
Fundamentals
ZTS:
$32.46B
ELAN:
$11.73B
ZTS:
$6.04
ELAN:
-$0.48
ZTS:
3.53
ELAN:
2.37
ZTS:
10.04
ELAN:
1.80
ZTS:
$9.51B
ELAN:
$4.89B
ZTS:
$6.73B
ELAN:
$2.42B
ZTS:
$3.95B
ELAN:
$755.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZTS vs. ELAN — Risk / Return Rank
ZTS
ELAN
ZTS vs. ELAN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zoetis Inc. (ZTS) and Elanco Animal Health Incorporated (ELAN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZTS | ELAN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.09 | ||
| Sortino ratioReturn per unit of downside risk | -4.42 | ||
| Omega ratioGain probability vs. loss probability | 0.68 | 1.31 | -0.64 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | 2.82 | -3.78 |
| Martin ratioReturn relative to average drawdown | -2.08 | 8.92 | -10.99 |
Loading charts...
Drawdowns
ZTS vs. ELAN - Drawdown Comparison
The maximum ZTS drawdown since its inception was -68.48%, smaller than the maximum ELAN drawdown of -78.00%. Use the drawdown chart below to compare losses from any high point for ZTS and ELAN.
Loading charts...
Drawdown Indicators
| ZTS | ELAN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -78.00% | +9.52% |
Max Drawdown (1Y)Largest decline over 1 year | -52.65% | -26.23% | -26.42% |
Max Drawdown (3Y)Largest decline over 3 years | -61.77% | -56.10% | -5.67% |
Max Drawdown (5Y)Largest decline over 5 years | -68.48% | -78.00% | +9.52% |
Max Drawdown (10Y)Largest decline over 10 years | -68.48% | — | — |
Current DrawdownCurrent decline from peak | -67.36% | -36.87% | -30.49% |
Average DrawdownAverage peak-to-trough decline | -14.94% | -39.76% | +24.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.31% | 8.28% | +16.03% |
Volatility
ZTS vs. ELAN - Volatility Comparison
The current volatility for Zoetis Inc. (ZTS) is 8.50%, while Elanco Animal Health Incorporated (ELAN) has a volatility of 14.37%. This indicates that ZTS experiences smaller price fluctuations and is considered to be less risky than ELAN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZTS | ELAN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.50% | 14.37% | -5.87% |
Volatility (6M)Calculated over the trailing 6-month period | 31.65% | 33.62% | -1.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.67% | 44.27% | -8.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.86% | 45.78% | -16.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.13% | 44.44% | -17.31% |
Dividends
ZTS vs. ELAN - Dividend Comparison
ZTS's dividend yield for the trailing twelve months is around 2.68%, while ELAN has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELAN Elanco Animal Health Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ZTS Zoetis Inc. | 2.68% | 1.59% | 1.06% | 0.76% | 0.89% | 0.41% | 0.48% | 0.50% | 0.59% | 0.58% | 0.71% | 0.69% |
Financials
ZTS vs. ELAN - Financials Comparison
This section allows you to compare key financial metrics between Zoetis Inc. and Elanco Animal Health Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZTS vs. ELAN - Profitability Comparison
ZTS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported a gross profit of 1.62B and revenue of 2.26B. Therefore, the gross margin over that period was 71.7%.
ELAN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a gross profit of 785.00M and revenue of 1.37B. Therefore, the gross margin over that period was 57.3%.
ZTS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported an operating income of 853.00M and revenue of 2.26B, resulting in an operating margin of 37.7%.
ELAN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported an operating income of 307.00M and revenue of 1.37B, resulting in an operating margin of 22.4%.
ZTS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zoetis Inc. reported a net income of 601.00M and revenue of 2.26B, resulting in a net margin of 26.6%.
ELAN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elanco Animal Health Incorporated reported a net income of 57.00M and revenue of 1.37B, resulting in a net margin of 4.2%.
Frequently Asked Questions
ZTS and ELAN have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ELAN has higher volatility (14.37%) compared to ZTS (8.50%). In terms of maximum drawdown, ZTS dropped -68.48% vs ELAN's -78.00%.
ELAN currently has the higher Sharpe Ratio (1.67 vs -1.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZTS and ELAN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer